Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research-Reference-Cited by-同舟云学术

Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research

Published:2019-04-04 Issue:5 Volume:40 Page:758-765
ISSN:0195-6108
Container-title:American Journal of Neuroradiology
language:en
Short-container-title:AJNR Am J Neuroradiol

Author:

Lasocki A.^ORCID,Gaillard F.^ORCID

Publisher

American Society of Neuroradiology (ASNR)

Subject

Clinical Neurology,Radiology Nuclear Medicine and imaging

Reference60 articles.

1. Louis DN , Ohgaki H , Wiestler OD , et al . World Health Organization Histological Classification of Tumors of the Central Nervous System. Lyon: International Agency for Research on Cancer; 2016

2. IDH1andIDH2Mutations in Gliomas

3. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas

4. The combination of checkpoint immunotherapy and targeted therapy in cancer

5. Molecular targeted therapy: Treating cancer with specificity

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic signatures derived from whole-brain MR-spectroscopy identify early tumor progression in high-grade gliomas using machine learning;Journal of Neuro-Oncology;2024-08-24

2. A validated LC-MS/MS method for determination of neuro-pharmacokinetic behavior of niraparib in brain tumor patients;Journal of Pharmaceutical and Biomedical Analysis;2024-08

3. The 2021 World Health Organization Central Nervous System Tumor Classification: The Spectrum of Diffuse Gliomas;Biomedicines;2024-06-18

4. The impact of diffusion and perfusion-weighted imaging on glioma grading;Oncologie;2024-05-22

5. Metabolic signatures derived from WB-MRS identify early tumor progression in high-grade gliomas using machine learning;2024-03-06